Tusind tak, CIRSE 2026! The enthusiasm around our booth and the Shockwave IVL Experience Center was electrifying. The strong engagement highlighted a shared commitment to advancing care for patients with complex peripheral artery disease. Thank you to everyone who stopped by our #ShockwaveIVL# booth and took part in our sessions. We're proud to be part of a community dedicated to pushing the boundaries of vascular care. See you next year! #CIRSE2026# #ShockwaveExperienceCenter# #ShochwaveIVL# #BTK# #FemPop# US Rx only. Safety Info:  Product availability may vary by country

#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.

When is #ShockwaveIVL# a suitable treatment for calcific coronary artery disease? Consult CALC!​ Shockwave IVL’s unique MOA and proven safety, effectiveness and ability to modify all types of calcium make it a good candidate for calcium modification in many scenarios.​ Swipe to learn more, and visit the CALC webpage for a deep dive:   ​ US Rx only. Safety Info: ​ Product availability may vary by country.

Remember to size for success with #ShockwaveIVL#. Watch a case where Dr. Paul Foley treats calcified bilateral CIA stenoses with 12.0 mm #ShockwaveL6# for an outstanding result. See what the Large and In Charge Shockwave L6 can do for your cases: US Rx only. Safety Info:  availability may vary by country.

What happens when you compare #ShockwaveIVL# head-to-head with atherectomy in the real world? The results speak for themselves. With 1,005 patients, the ROLLING-STONE Registry is the largest prospective, multicenter study to include a head-to-head comparison of #ShockwaveIVL# and atherectomy in a real-world, all-comers population. The study confirmed strong procedural success and intraprocedural safety with Shockwave IVL. It also demonstrated a favorable 30-day MACE rate and a significantly lower 1-year MACE after propensity score matching compared with atherectomy. Read the full summary:  US Rx only. Safety Info:  Product availability may vary by country.

Check out the IVUS runs pre- and post-#ShockwaveIVL# ⚡ Dr. Ash Patel used #ShockwaveE8# to treat a 55M patient with CLTI to restore blood flow to his heavily calcified distal PT and lateral plantar arteries. Learn more about Shockwave E8 for below the knee and beyond the ankle: US Rx only. Safety Info: availability may vary by country.

Proper balloon preparation is an important step in every #ShockwaveIVL# procedure 🎈 Watch this step-by-step guide to balloon preparation and the instruments required to help minimize air bubbles during procedures with both peripheral and coronary Shockwave IVL devices (excluding Shockwave Javelin). Because while calcium can be challenging to treat, preparing your Shockwave IVL balloon doesn't have to be. 👉 Check the website to learn more: #BalloonPreparation# #PeripheralIVL# #CoronaryIVL# #MedEd# Filmed in a demonstration environment. Please ensure adherence to sterile practices. Refer to the Instructions for Use or contact your local representative for further guidance. US Rx only. Safety Info:   Product availability may vary by country.

Safety is in our DNA and MOA. #ShockwaveIVL# delivers shockwaves that crack hard calcium without damaging soft tissue — the product of nearly a decade spent refining extracorporeal lithotripsy principles into a purpose-built vascular solution. The combination of Shockwave's acoustic waveform and energy delivery is what makes Shockwave IVL predictable safe and consistently effective. Learn more about our proven MOA by reading our CMO Nick West’s latest article in @CardiacInterv:  US Rx only. Safety Info: availability may vary by country.

Joining CITIC2026? Don’t miss our #ShockwaveIVL# symposium! Led by Prof. Flavio Ribichini (@FlavioRibichini), Dr. Carla Agatiello (@CarlaAgatiello), and Dr. Félix Damas (@felixdamasds), this session will explore the role of Shockwave IVL in addressing complex coronary calcium. Discover key insights from EMPOWER CAD and gain a deeper understanding of how Shockwave IVL performs in challenging lesions. Save the date and join the discussion as we advance the standard of care in coronary intervention. Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

#AMP2026# is a wrap! Thank you to everyone who joined our #ShockwaveIVL# symposium. We hope the case-based insights and expert perspectives spark new possibilities in your approach to patient care. A special thank you to Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) for sharing their expertise and helping make this session such a success. We appreciate you! Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: Product availability may vary by country.